基本信息
文件名称:2021 SEER 编码和分期手册可报告恶性肿瘤示例.pdf
文件大小:170.35 KB
总页数:6 页
更新时间:2025-05-17
总字数:约2.38万字
文档摘要

AppendixE1-2021SEERProgramCodingandStagingManual

ReportableExamples

AsreferencedintheReportabilityinstructionsofthe2021SEERProgramCodingandStagingManual

ReportableMalignantExamples

#Diagnosis/ConditionNotes

1Atypicalfibroxanthoma(superficialmalignantfibrousTheinformationinparenthesesprovidesmoredetailandconfirmsareportablemalignancy.

histiocytoma)

2PositivehistologyfromneedlebiopsyfollowedbyThiscaseisreportablebasedonpositiveneedlebiopsy.

negativeresection

3Biopsy-provensquamouscellcarcinomaofthenippleThiscaseisreportable.Thefactthatnoresidualmalignancywasfoundinthelaterspecimendoes

withasubsequentareolarresectionshowingforeignnotdisprovethemalignancydiagnosedbythebiopsy.

bodygranulomatousreactiontosuturematerialandno

evidenceofresidualmalignancyinthenipple

4Ulceratedhistologicallymalignantspindlecellneoplasm,Atypicalfibroxanthomaisasuperficialformofamalignantfibroushistiocytoma.Thiscaseis

consistentwithatypicalfibroxanthoma;anexhaustivereportable.Thepathologisthasthefinalsayonbehaviorforaparticularcase.Inthiscase,the

immunohistochemicalwork-upshowsnomelanocytic,pathologiststatesthatthistumorismalignant.

epithelialorvasculardifferentiation

5AggressiveadultgranulosacelltumorwithoneoftwoThiscaseisreportablebecausemalignantgranulosacelltumorisreportable.Thelymphnode

lymphnodespositiveformalignantmetastaticgranulosametastasesprovemalignancy.

celltumor

6CarcinoidoftheappendixfoundonappendectomyCarcinoidtumor,NOSisreportable(8240/3).

7Microcarcinoidtumorsofthest